<DOC>
	<DOCNO>NCT01777607</DOCNO>
	<brief_summary>The use Impella RP safe , feasible provide hemodynamic benefit patient right ventricular failure .</brief_summary>
	<brief_title>The Use Impella RP Support System Patients With Right Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Patients develop sign right ventricular failure either : A ) within 48 hour postimplantation FDA approve implantable surgical LVAD ( leave ventricular assist device ) ( Cohort A ) B ) subsequent postcardiotomy shock within 48 hour post surgery post myocardial infarction ( Cohort B ) . 2 . Age â‰¥18 year old 3 . Signed Informed consent Exclusion Criteria 1 . INTERMACS 1 patient ( Critical cardiogenic shock patient `` crash burning '' , lifethreatening hypotension rapidly escalate inotropic pressor support , critical organ hypoperfusion often confirm worsen acidosis lactate level ) 2 . Evidence acute neurologic injury 3 . RA ( right atrium ) , RV ( right Ventricle ) and/or PA ( pulmonary artery ) thrombus 4 . Intolerance anticoagulant antiplatelet therapy 5 . Existing congenital heart disease would preclude insertion device . 6 . Participation clinical investigation likely confound study result affect study outcome 7 . Acute Myocardial Infarction ( AMI ) mechanical complication ( ventricular septal defect , myocardial rupture , papillary muscle rupture )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>